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In the title salt hydrate, C11H12ClN2
+ Cl
  H2O, the quinolin-
ium core is essentially planar (r.m.s. deviation = 0.027 A ˚ ) with
the chloroethyl side chain being almost orthogonal to the core
[C—N—C—C torsion angle =  80.0 (3) ]. In the crystal
packing, the water molecule bridges three species, forming
donor interactions to two chloride anions and accepting a
hydrogen bond from the quinolinium H atom. The chloride
anion accepts a hydrogen bond from the amine N atom with
the result that a two-dimensional supramolecular array is
formed in the ac plane. A C—H   Cl interaction also occurs.
Related literature
For background to malaria, see: Snow et al. (1999); Breman
(2001); World Health Organization (1999). For background
information on the pharmacological activity of quinoline
derivatives, see: Elslager et al. (1969); Font et al. (1997);
Kaminsky & Meltzer (1968); Musiol et al. (2006); Nakamura et
al. (1999); Palmer et al. (1993); Ridley (2002); Sloboda et al.
(1991); Tanenbaum & Tuffanelli (1980); Warshakoon et al.
(2006). For recent studies on quinoline-based anti-malarials,
see: Andrade et al. (2007); Cunico et al. (2006); da Silva et al.
(2003); de Souza et al. (2005). For a related crystallographic
study on a neutral species related to the title compound, see:









a = 18.7513 (7) A ˚
b = 14.1030 (5) A ˚
c = 4.606 (1) A ˚
V = 1218.1 (3) A ˚ 3
Z =4
Mo K  radiation
  = 0.51 mm
 1
T = 120 K
0.46   0.03   0.03 mm
Data collection
Bruker–Nonius 95mm CCD camera
on  -goniostat diffractometer
Absorption correction: multi-scan
(SADABS; Sheldrick, 2003)
Tmin = 0.816, Tmax =1
11264 measured reﬂections
2681 independent reﬂections













 max = 0.22 e A ˚  3
 min =  0.21 e A ˚  3
Absolute structure: Flack (1983),
1123 Friedel pairs
Flack parameter: 0.03 (6)
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N1—H1   O1
i 0.88 1.84 2.710 (2) 172
N2—H2   Cl2 0.88 2.41 3.2298 (18) 155
O1—H1w   Cl2
ii 0.84 2.32 3.1288 (19) 161
O1—H2w   Cl2 0.84 2.29 3.1204 (19) 173
C5—H5   Cl2 0.95 2.82 3.730 (2) 161
Symmetry codes: (i) x þ 1
2; y þ 3
2;z; (ii) x;y;z þ 1.
Data collection: COLLECT (Hooft, 1998); cell reﬁnement:
DENZO (Otwinowski & Minor, 1997) and COLLECT; data reduc-
tion: DENZO and COLLECT; program(s) used to solve structure:
SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne structure:
SHELXL97 (Sheldrick, 2008); molecular graphics: DIAMOND
(Brandenburg, 2006); software used to prepare material for publi-
cation: publCIF (Westrip, 2009).
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Comment
The majority of drugs used against malaria, such as chloroquine (Tanenbaum & Tuffanelli, 1980), mefloquine (Palmer et
al., 1993), primaquine (Elslager et al., 1969) and amodiaquine (Ridley, 2002) possess a quinoline ring which has been the
mainstay of malaria chemotherapy for much of the past 40 years (Font et al., 1997; Kaminsky & Meltzer, 1968; Musiol et al.,
2006; Nakamura et al., 1999; Sloboda et al., 1991; Warshakoon et al., 2006). However, their effectiveness has been seriously
eroded in recent years, mainly as a result of the development of parasite resistance (Ridley, 2002). Malaria remains one of
the most important diseases of humans with over half of the world population at risk of infection. It affects mainly those
living in tropical and subtropical areas with an incidence of 500 million cases per year globally (Snow et al., 1999; Breman,
2001; World Health Organization, 1999). As part of our studies (de Souza et al., 2005; Andrade et al., 2007; da Silva et al.,
2003; Cunico et al., 2006) of drugs for neglected diseases, various quinoline derivatives with potential antimalarial activities
have been investigated. It was during this study that the the title salt hydrate, (I), was characterized.
The quinolinium core in (I), Fig. 1, is essentially planar with a RMS deviation of the 10 atoms comprising the framework
being 0.027 Å, with a maximum deviation exhibited by the C3 atom [0.031 (2) Å]. The amine side-chain deviates signific-
antly from this plane starting with the N2 atom which lies 0.082 (2) Å above the plane. Further along the side-chain, the
C11 and Cl1 atoms are almost orthogonal to the quinolinium core as seen in the magnitude of the C3/N2/C10/C11 torsion
angle of -80.0 (3) °. The N—H group is orientated towards the aromatic ring. These conformational features are as found
in the neutral parent compound (Kaiser et al. (2009). The most significant difference between the geometric parameters in
the neutral and protonated forms is found in the angles subtended at the N1 atom, i.e. this has widened considerably in (I),
121.00 (19) Å, compared with 115.3 (2) ° in the neutral form, consistent with protonation in the former.
As expected from the composition of (I), there are significant hydrogen bonding interactions operating in the crystal
structure, Table 1. The quinolinium nitrogen atom forms a donor interaction to the water molecule which in turn forms two
donor interactions to the Cl2 anion. The Cl2 anion accepts a hydrogen bond from the amine-H with the result that a 2-D
supramolecular array is formed in the ac plane, Fig. 2. Additional stability to the array is provided by C–H···Cl interactions
involving the Cl1 atom, Table 1. Layers stack along the b axis to consolidate the crystal structure.
Experimental
A mixture of 7-chloro-N-(2-hydroxyethyl)quinolin-4-amine) (Kaiser et al., 2009) (0.5 g, 2.2 mmol), thionyl chloride (33
ml, 45 mmol) and DMF (0.3 ml, 0.22 mol) was stirred under nitrogen at room temperature for 24 h. The resulting mixture
was treated with a saturated aqueous solution of sodium bicarbonate and extracted with ethyl acetate. The combined organic
phases were dried over anhydrous sodium sulfate and concentrated under reduced pressure to yield solid (I); yield: 94%.The
compound was recrystallized from ethanol, m. pt.: 402–403 K. The melting point of the free base was reported to be 427
K (Elderfield et al., 1946).supplementary materials
sup-2
Refinement
The C-bound H atoms were geometrically placed (C–H = 0.95–0.99 Å) and refined as riding with Uiso(H) = 1.2Ueq(C). The
N-bound H atoms were located from a difference map and included in their idealized positions with N–H = 0.88 Å, and
with Uiso(H) = 1.2Ueq(N). The water-H atoms were located from a difference map and refined with O–H = 0.840±0.001
Å and H···H = 1.39±0.01 Å, and with Uiso(H) = 1.5Ueq(O).
Figures
Fig. 1. The asymmetric unit in (I) showing the atom-labelling scheme and displacement el-
lipsoids at the 50% probability level. Hydrogen bonding between the water molecule and Cl2
anion (orange dashed line), and between the amine-N1—H and Cl2 anion (blue dashed line)
are highlighted.
Fig. 2. Supramolecular 2-D array in (I) in the ac plane. The N–H···O (blue), N–H···Cl and
O–H···Cl (orange), and C–H···O (green) interactions are shown as dashed lines. Colour code:




+·Cl–·H2O F000 = 544
Mr = 261.14 Dx = 1.424 Mg m−3
Orthorhombic, Pna21 Mo Kα radiation, λ = 0.71070 Å
Hall symbol: P 2c -2n Cell parameters from 1650 reflections
a = 18.7513 (7) Å θ = 2.9–27.5º
b = 14.1030 (5) Å µ = 0.51 mm−1
c = 4.6060 (10) Å T = 120 K
V = 1218.1 (3) Å3 Needle, colourless
Z = 4 0.46 × 0.03 × 0.03 mm
Data collection
Bruker–Nonius 95mm CCD camera on κ-goniostat
diffractometer 2681 independent reflections
Radiation source: Bruker-Nonius FR591 rotating an-
ode 2390 reflections with I > 2σ(I)
Monochromator: graphite Rint = 0.049
Detector resolution: 9.091 pixels mm-1 θmax = 27.5º
T = 120 K θmin = 3.1º
φ & ω scans h = −19→24supplementary materials
sup-3
Absorption correction: multi-scan
(SADABS; Sheldrick, 2003) k = −18→18
Tmin = 0.816, Tmax = 1 l = −5→5
11264 measured reflections
Refinement
Refinement on F2 Hydrogen site location: inferred from neighbouring
sites
Least-squares matrix: full H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.032
  w = 1/[σ2(Fo
2) + (0.0173P)2 + 0.5206P]
where P = (Fo
2 + 2Fc
2)/3
wR(F2) = 0.065 (Δ/σ)max = 0.001
S = 1.06 Δρmax = 0.22 e Å−3
2681 reflections Δρmin = −0.21 e Å−3
151 parameters Extinction correction: none
4 restraints Absolute structure: Flack (1983), 1123 Friedel pairs
Primary atom site location: structure-invariant direct
methods
Flack parameter: 0.03 (6)
Secondary atom site location: difference Fourier map
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
Cl1 0.13741 (3) 0.81412 (4) 0.18205 (16) 0.02165 (12)
Cl2 0.21007 (3) 0.53250 (3) 0.01935 (15) 0.02136 (12)
O1 0.10851 (8) 0.59720 (11) 0.5181 (4) 0.0271 (4)
H1W 0.1283 0.5858 0.6780 0.041*
H2W 0.1365 0.5852 0.3805 0.041*
N1 0.48246 (10) 0.82732 (12) 0.3467 (4) 0.0188 (4)
H1 0.5241 0.8470 0.4104 0.023*
N2 0.29024 (9) 0.73519 (11) 0.0155 (4) 0.0163 (3)
H2 0.2742 0.6796 0.0728 0.020*
C1 0.44596 (12) 0.88075 (15) 0.1575 (5) 0.0203 (5)
H1A 0.4657 0.9397 0.0982 0.024*
C2 0.38179 (12) 0.85382 (14) 0.0472 (5) 0.0184 (4)supplementary materials
sup-4
H2A 0.3572 0.8943 −0.0839 0.022*
C3 0.35148 (11) 0.76568 (14) 0.1268 (4) 0.0158 (5)
C4 0.39002 (11) 0.70904 (15) 0.3390 (5) 0.0152 (4)
C5 0.36387 (12) 0.62250 (15) 0.4527 (4) 0.0179 (5)
H5 0.3194 0.5985 0.3873 0.021*
C6 0.40215 (12) 0.57290 (15) 0.6566 (5) 0.0208 (5)
H6 0.3837 0.5153 0.7328 0.025*
C7 0.46856 (13) 0.60686 (16) 0.7533 (5) 0.0230 (5)
H7 0.4951 0.5715 0.8917 0.028*
C8 0.49518 (11) 0.69039 (15) 0.6493 (5) 0.0192 (5)
H8 0.5399 0.7133 0.7159 0.023*
C9 0.45584 (11) 0.74244 (15) 0.4426 (4) 0.0158 (5)
C10 0.24785 (13) 0.78772 (16) −0.1954 (5) 0.0181 (5)
H10A 0.2162 0.7429 −0.2993 0.022*
H10B 0.2802 0.8167 −0.3402 0.022*
C11 0.20268 (11) 0.86510 (15) −0.0584 (4) 0.0177 (5)
H11A 0.1783 0.9017 −0.2125 0.021*
H11B 0.2337 0.9091 0.0515 0.021*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
Cl1 0.0166 (3) 0.0257 (3) 0.0227 (3) −0.0021 (2) 0.0006 (2) 0.0039 (3)
Cl2 0.0218 (3) 0.0193 (2) 0.0230 (3) −0.0009 (2) −0.0043 (2) 0.0008 (3)
O1 0.0220 (9) 0.0335 (9) 0.0258 (8) 0.0085 (7) 0.0002 (8) 0.0060 (9)
N1 0.0138 (10) 0.0193 (10) 0.0234 (10) −0.0035 (8) −0.0001 (8) −0.0019 (8)
N2 0.0164 (9) 0.0140 (8) 0.0186 (8) 0.0010 (7) −0.0025 (8) 0.0033 (9)
C1 0.0211 (11) 0.0162 (10) 0.0235 (11) −0.0012 (9) 0.0026 (10) 0.0002 (10)
C2 0.0187 (11) 0.0169 (10) 0.0196 (11) 0.0036 (9) 0.0018 (10) 0.0010 (10)
C3 0.0136 (11) 0.0169 (10) 0.0168 (12) 0.0041 (8) 0.0021 (8) −0.0028 (8)
C4 0.0135 (11) 0.0158 (10) 0.0163 (11) 0.0040 (8) 0.0009 (8) −0.0036 (8)
C5 0.0172 (12) 0.0158 (10) 0.0206 (12) −0.0003 (9) −0.0029 (8) −0.0015 (9)
C6 0.0235 (12) 0.0156 (10) 0.0235 (11) 0.0031 (9) −0.0009 (11) 0.0002 (10)
C7 0.0237 (13) 0.0235 (12) 0.0217 (13) 0.0108 (10) −0.0031 (9) −0.0017 (9)
C8 0.0139 (11) 0.0241 (11) 0.0196 (12) 0.0031 (9) −0.0012 (10) −0.0062 (9)
C9 0.0160 (11) 0.0162 (10) 0.0151 (11) 0.0020 (9) 0.0022 (8) −0.0032 (8)
C10 0.0175 (12) 0.0193 (11) 0.0175 (11) 0.0016 (9) −0.0032 (9) 0.0011 (8)
C11 0.0155 (12) 0.0186 (11) 0.0192 (12) −0.0011 (9) 0.0009 (8) 0.0029 (8)
Geometric parameters (Å, °)
Cl1—C11 1.800 (2) C4—C5 1.416 (3)
O1—H1W 0.8400 C5—C6 1.374 (3)
O1—H2W 0.8401 C5—H5 0.9500
N1—C1 1.340 (3) C6—C7 1.407 (3)
N1—C9 1.370 (3) C6—H6 0.9500
N1—H1 0.8800 C7—C8 1.366 (3)
N2—C3 1.329 (3) C7—H7 0.9500
N2—C10 1.457 (3) C8—C9 1.411 (3)supplementary materials
sup-5
N2—H2 0.8800 C8—H8 0.9500
C1—C2 1.360 (3) C10—C11 1.519 (3)
C1—H1A 0.9500 C10—H10A 0.9900
C2—C3 1.415 (3) C10—H10B 0.9900
C2—H2A 0.9500 C11—H11A 0.9900
C3—C4 1.454 (3) C11—H11B 0.9900
C4—C9 1.405 (3)
H1W—O1—H2W 110.3 C5—C6—H6 119.8
C1—N1—C9 121.00 (19) C7—C6—H6 119.8
C1—N1—H1 119.5 C8—C7—C6 120.4 (2)
C9—N1—H1 119.5 C8—C7—H7 119.8
C3—N2—C10 124.33 (17) C6—C7—H7 119.8
C3—N2—H2 117.8 C7—C8—C9 119.6 (2)
C10—N2—H2 117.8 C7—C8—H8 120.2
N1—C1—C2 122.5 (2) C9—C8—H8 120.2
N1—C1—H1A 118.7 N1—C9—C4 120.24 (19)
C2—C1—H1A 118.7 N1—C9—C8 118.81 (19)
C1—C2—C3 120.2 (2) C4—C9—C8 120.95 (19)
C1—C2—H2A 119.9 N2—C10—C11 113.12 (18)
C3—C2—H2A 119.9 N2—C10—H10A 109.0
N2—C3—C2 122.08 (19) C11—C10—H10A 109.0
N2—C3—C4 120.73 (18) N2—C10—H10B 109.0
C2—C3—C4 117.2 (2) C11—C10—H10B 109.0
C9—C4—C5 117.89 (19) H10A—C10—H10B 107.8
C9—C4—C3 118.74 (19) C10—C11—Cl1 110.35 (15)
C5—C4—C3 123.36 (19) C10—C11—H11A 109.6
C6—C5—C4 120.7 (2) Cl1—C11—H11A 109.6
C6—C5—H5 119.6 C10—C11—H11B 109.6
C4—C5—H5 119.6 Cl1—C11—H11B 109.6
C5—C6—C7 120.4 (2) H11A—C11—H11B 108.1
C9—N1—C1—C2 −1.0 (3) C5—C6—C7—C8 1.2 (3)
N1—C1—C2—C3 −1.1 (4) C6—C7—C8—C9 −0.4 (3)
C10—N2—C3—C2 −0.3 (3) C1—N1—C9—C4 1.2 (3)
C10—N2—C3—C4 179.32 (19) C1—N1—C9—C8 −177.8 (2)
C1—C2—C3—N2 −177.4 (2) C5—C4—C9—N1 −177.87 (18)
C1—C2—C3—C4 2.9 (3) C3—C4—C9—N1 0.7 (3)
N2—C3—C4—C9 177.64 (19) C5—C4—C9—C8 1.2 (3)
C2—C3—C4—C9 −2.7 (3) C3—C4—C9—C8 179.73 (18)
N2—C3—C4—C5 −3.9 (3) C7—C8—C9—N1 178.23 (19)
C2—C3—C4—C5 175.8 (2) C7—C8—C9—C4 −0.8 (3)
C9—C4—C5—C6 −0.4 (3) C3—N2—C10—C11 −80.0 (3)
C3—C4—C5—C6 −178.9 (2) N2—C10—C11—Cl1 −63.9 (2)
C4—C5—C6—C7 −0.8 (3)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
N1—H1···O1i 0.88 1.84 2.710 (2) 172supplementary materials
sup-6
N2—H2···Cl2 0.88 2.41 3.2298 (18) 155
O1—H1w···Cl2ii 0.84 2.32 3.1288 (19) 161
O1—H2w···Cl2 0.84 2.29 3.1204 (19) 173
C5—H5···Cl2 0.95 2.82 3.730 (2) 161
Symmetry codes: (i) x+1/2, −y+3/2, z; (ii) x, y, z+1.supplementary materials
sup-7
Fig. 1supplementary materials
sup-8
Fig. 2